Acrivon Therapeutics, Inc. Common Stock (ACRV) Insider Trading
- $67,369,250.00
- $35,718.97
- April 11, 2024
- Ltd Chione
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 11, 2024 | Major Shareholder | 2,353,000 | $8.50 | Buy | $20,000,500.00 | |
| June 26, 2023 | Major Shareholder | 16 | $12.93 | Sell | $206.88 | |
| June 14, 2023 | Major Shareholder | 893 | $12.13 | Sell | $10,832.09 | |
| June 12, 2023 | Major Shareholder | 2,000 | $12.34 | Sell | $24,680.00 | |
| Nov. 17, 2022 | Director | 3,389,500 | $12.50 | Buy | $42,368,750.00 | |
| Nov. 17, 2022 | Major Shareholder | 400,000 | $12.50 | Buy | $5,000,000.00 |
Insiders are both buying and selling Acrivon Therapeutics, Inc. Common Stock stock.
The insider traders at Acrivon Therapeutics, Inc. Common Stock are: Ltd Chione, Perceptive Advisors Llc, and Ra Capital Management, L.P.
The most active insider trader at Acrivon Therapeutics, Inc. Common Stock is Ltd Chione with 4 trades.
Ltd Chione has sold the most Acrivon Therapeutics, Inc. Common Stock stock with a total value of $35,925.85.
Ra Capital Management, L.P. has bought the most Acrivon Therapeutics, Inc. Common Stock stock with a total value of $84,737,500.00.
The most recent insider trade for Acrivon Therapeutics, Inc. Common Stock was on April 11, 2024.
The single biggest insider buy for Acrivon Therapeutics, Inc. Common Stock was from Ra Capital Management, L.P. with a total value of $42,368,750.00 on Nov. 17, 2022.
The single biggest insider sell for Acrivon Therapeutics, Inc. Common Stock was from Ltd Chione with a total value of $24,680.00 on June 12, 2023.